Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

High incidence of fatty liver and insulin resistance in long-term adult survivors of childhood SCT

Abstract

Overweight/obesity among adult survivors of childhood SCT has been considered to be predictive of eventual development of metabolic abnormalities. Fatty liver is increasingly recognized as a major cause of liver-related morbidity and mortality in the general population. However, the real incidence of fatty liver in adult survivors of SCT has not been fully elucidated. We determined whether adult survivors are at risk for overweight/obesity, metabolic abnormalities and fatty liver and whether these risks are associated with cranial radiotherapy (CRT) before SCT. Among the 51 patients (30 males), only two male patients were overweight/obese at the last evaluation. On the other hand, 9 male (30%) and 15 female (71%) patients were underweight. Fatty liver was diagnosed in 11 male (37%) and 10 female (48%) patients during the follow-up period, although patients who had fatty liver did not tend to be overweight/obese. Significantly more patients who received CRT before SCT developed fatty liver with insulin resistance than those who did not (P<0.05). Even patients who are not overweight/obese may develop fatty liver and metabolic abnormalities. We recommend that healthcare professionals recognize these risks and give life-long attention to detecting, preventing and treating late complications after SCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Nandagopal R, Laverdière C, Mulrooney D, Hudson MM, Meacham L . Endocrine late effects of childhood cancer therapy: a report from the Children's Oncology Group. Horm Res 2008; 69: 65–74.

    CAS  PubMed  Google Scholar 

  2. Sklar CA, Mertens AC, Walter A, Mitchell D, Nesbit ME, O’Leary M et al. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Onco 2000; 35: 91–95.

    Article  CAS  Google Scholar 

  3. Link K, Moëll C, Garwicz S, Cavallin-Ståhl E, Björk J, Thilén U et al. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab 2004; 89: 5003–5012.

    Article  CAS  PubMed  Google Scholar 

  4. Brennan BM, Rahim A, Blum WF, Adams JA, Eden OB, Shalet SM . Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity? Clin Endocrinol 1999; 50: 163–169.

    Article  CAS  Google Scholar 

  5. Facchini FS, Hua N, Abbasi F, Reaven GM . Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001; 86: 3574–3578.

    Article  CAS  PubMed  Google Scholar 

  6. Fujimoto WY, Bergstrom RW, Boyko EJ, Chen KW, Leonetti DL, Newell-Morris L et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care 1999; 22: 1808–1812.

    Article  CAS  PubMed  Google Scholar 

  7. Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R . Visceral fat is an independent predictor of all-cause mortality in men. Obesity 2006; 14: 336–341.

    Article  PubMed  Google Scholar 

  8. Moitra J, Mason MM, Olive M, Krylov D, Gavrilova O, Marcus-Samuels B et al. Life without white fat: a transgenic mouse. Genes Dev 1998; 12: 3168–3181.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Angulo P . Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221–1231.

    Article  CAS  PubMed  Google Scholar 

  10. Teli MR, James OF, Burt AD, Bennett MK, Day CP . The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995; 22: 1714–1719.

    Article  CAS  PubMed  Google Scholar 

  11. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132: 112–117.

    Article  CAS  PubMed  Google Scholar 

  12. Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004; 19: 854–858.

    Article  PubMed  Google Scholar 

  13. Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G . Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 2000; 45: 1929–1934.

    Article  CAS  PubMed  Google Scholar 

  14. Donati G, Stagni B, Piscaglia F, Venturoli N, Morselli-Labate AM, Rasciti L et al. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut 2004; 53: 1020–1023.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Cohen A, Duell T, Socié G, van Lint MT, Weiss M, Tichelli A et al. Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT Late-Effects Working Party retrospective data. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1999; 23: 1043–1047.

    Article  CAS  PubMed  Google Scholar 

  16. Nysom K, Holm K, Michaelsen KF, Hertz H, Jacobsen N, Müller J et al. Degree of fatness after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant 2001; 27: 817–820.

    Article  CAS  PubMed  Google Scholar 

  17. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. World Health Organ Tech Rep Ser 2000; 894: i–xii, 1–253.

    Google Scholar 

  18. Ashwell M, Cole TJ, Dixon AK . Ratio of waist circumference to height is strong predictor of intra-abdominal fat. BMJ 1996; 313: 559–560.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Savva SC, Tornaritis M, Savva ME, Kourides Y, Panagi A, Silikiotou N et al. Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes Relat Metab Disord 2000; 24: 1453–1458.

    Article  CAS  PubMed  Google Scholar 

  20. Hsieh SD, Yoshinaga H, Muto T . Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women. Int J Obes Relat Metab Disord 2003; 27: 610–616.

    Article  CAS  PubMed  Google Scholar 

  21. Matsuzawa Y . Metabolic Syndrome-definition and diagnostic criteria in Japan. J Atheroscler Thromb 2005; 12: 301.

    Article  PubMed  Google Scholar 

  22. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S . Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 2003; 38: 954–961.

    Article  PubMed  Google Scholar 

  23. Davidson LE, Kuk JL, Church TS, Ross R . Protocol for measurement of liver fat by computed tomography. J Appl Physiol 2006; 100: 864–868.

    Article  PubMed  Google Scholar 

  24. Shinagawa T, Tomita Y, Ishiguro H, Matsumoto M, Shimizu T, Yasuda Y et al. Final height and growth hormone secretion after bone marrow transplantation in children. Endocr J 2001; 48: 133–138.

    Article  CAS  PubMed  Google Scholar 

  25. Tanner JM, Whitehouse RH . Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976; 51: 170–179.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Prader A . Testicular size: assessment and clinical importance. Triangle 1966; 7: 240–243.

    CAS  PubMed  Google Scholar 

  27. Oeffinger KC, Mertens AC, Sklar CA, Yasui Y, Fears T, Stovall M et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2003; 21: 1359–1365.

    Article  PubMed  Google Scholar 

  28. Van Dongen-Melman JE, Hokken-Koelega AC, Hählen K, De Groot A, Tromp CG, Egeler RM . Obesity after successful treatment of acute lymphoblastic leukemia in childhood. Pediatr Res 1995; 38: 86–90.

    Article  CAS  PubMed  Google Scholar 

  29. Warner JT, Bell W, Webb DK, Gregory JW . Daily energy expenditure and physical activity in survivors of childhood malignancy. Pediatr Res 1998; 43: 607–613.

    Article  CAS  PubMed  Google Scholar 

  30. Strosberg AD, Issad T . The involvement of leptin in humans revealed by mutations in leptin and leptin receptor genes. Trends Pharmacol Sci 1999; 20: 227–230.

    Article  CAS  PubMed  Google Scholar 

  31. Ross JA, Oeffinger KC, Davies SM, Mertens AC, Langer EK, Kiffmeyer WR et al. Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2004; 22: 3558–3562.

    Article  CAS  PubMed  Google Scholar 

  32. The Ministry of Health, Labor and Welfare of Japan. The National Health and Nutrition Survey of Japan in 2004.

  33. Ablamunits V, Weisberg SP, Lemieux JE, Combs TP, Klebanov S . Reduced adiposity in ob/ob mice following total body irradiation and bone marrow transplantation. Obesity 2007; 15: 1419–1429.

    Article  CAS  PubMed  Google Scholar 

  34. Bingham NC, Anderson KK, Reuter AL, Stallings NR, Parker KL . Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome. Endocrinology 2008; 149: 2138–2148.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Yki-Järvinen H . Fat in the liver and insulin resistance. Ann Med 2005; 37: 347–356.

    Article  PubMed  Google Scholar 

  36. Agarwal AK, Garg A . Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways. Trends Endocrinol Metab 2003; 14: 214–221.

    Article  CAS  PubMed  Google Scholar 

  37. Kotronen A, Westerbacka J, Bergholm R, Pietiläinen KH, Yki-Järvinen H . Liver fat in the metabolic syndrome. J Clin Endocrinol Metab 2007; 92: 3490–3497.

    Article  CAS  PubMed  Google Scholar 

  38. Goto T, Onuma T, Takebe K, Kral JG . The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 1995; 19: 839–840.

    Google Scholar 

  39. Tiikkainen M, Häkkinen AM, Korsheninnikova E, Nyman T, Mäkimattila S, Yki-Järvinen H . Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes 2004; 53: 2169–2176.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Laurie E. Cohen for advice and critical review of the article. We also thank all the medical staff at Tokai University Hospital for patient care. This work was supported in part by a Research Grant (H20-015) on allergic disease and immunology from the Ministry of Health, Labor and Welfare of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H Ishiguro.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tomita, Y., Ishiguro, H., Yasuda, Y. et al. High incidence of fatty liver and insulin resistance in long-term adult survivors of childhood SCT. Bone Marrow Transplant 46, 416–425 (2011). https://doi.org/10.1038/bmt.2010.144

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2010.144

Keywords

This article is cited by

Search

Quick links